LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | GSK1059615 | 0.12 | uM | LJP6 | 3 | C05 | 72 | hr | 1401 | 3324 | 4223 | 0.7871 | 0.6814 |
SK-BR-3 | GSK1904529A | 0.12 | uM | LJP6 | 1 | H23 | 72 | hr | 1401 | 3679 | 4223 | 0.8712 | 0.8072 |
SK-BR-3 | GSK1904529A | 0.12 | uM | LJP6 | 2 | H23 | 72 | hr | 1401 | 3558 | 4223 | 0.8425 | 0.7643 |
SK-BR-3 | GSK1904529A | 0.12 | uM | LJP6 | 3 | H23 | 72 | hr | 1401 | 4073 | 4223 | 0.9645 | 0.9468 |
SK-BR-3 | Omipalisib | 0.12 | uM | LJP6 | 1 | N05 | 72 | hr | 1401 | 1260 | 4223 | 0.2984 | -0.0502 |
SK-BR-3 | Omipalisib | 0.12 | uM | LJP6 | 2 | N05 | 72 | hr | 1401 | 1441 | 4223 | 0.3412 | 0.0140 |
SK-BR-3 | Omipalisib | 0.12 | uM | LJP6 | 3 | N05 | 72 | hr | 1401 | 1386 | 4223 | 0.3282 | -0.0055 |
SK-BR-3 | GSK 690693 | 0.12 | uM | LJP5 | 1 | F23 | 72 | hr | 1401 | 2627 | 4223 | 0.6221 | 0.4343 |
SK-BR-3 | GSK 690693 | 0.12 | uM | LJP5 | 2 | F23 | 72 | hr | 1401 | 2838 | 4223 | 0.6720 | 0.5091 |
SK-BR-3 | GSK 690693 | 0.12 | uM | LJP5 | 3 | F23 | 72 | hr | 1401 | 3333 | 4223 | 0.7892 | 0.6845 |
SK-BR-3 | GW843682X | 0.12 | uM | LJP6 | 1 | B17 | 72 | hr | 1401 | 2224 | 4223 | 0.5266 | 0.2915 |
SK-BR-3 | GW843682X | 0.12 | uM | LJP6 | 2 | B17 | 72 | hr | 1401 | 2126 | 4223 | 0.5034 | 0.2568 |
SK-BR-3 | GW843682X | 0.12 | uM | LJP6 | 3 | B17 | 72 | hr | 1401 | 2453 | 4223 | 0.5809 | 0.3727 |
SK-BR-3 | HG-5-113-01 | 0.12 | uM | LJP5 | 1 | B11 | 72 | hr | 1401 | 3962 | 4223 | 0.9382 | 0.9075 |
SK-BR-3 | HG-5-113-01 | 0.12 | uM | LJP5 | 2 | B11 | 72 | hr | 1401 | 4296 | 4223 | 1.0173 | 1.0258 |
SK-BR-3 | HG-5-113-01 | 0.12 | uM | LJP5 | 3 | B11 | 72 | hr | 1401 | 3866 | 4223 | 0.9154 | 0.8734 |
SK-BR-3 | HG-5-88-01 | 0.12 | uM | LJP6 | 1 | A23 | 72 | hr | 1401 | 3399 | 4223 | 0.8049 | 0.7079 |
SK-BR-3 | HG-5-88-01 | 0.12 | uM | LJP6 | 2 | A23 | 72 | hr | 1401 | 3478 | 4223 | 0.8236 | 0.7359 |
SK-BR-3 | HG-5-88-01 | 0.12 | uM | LJP6 | 3 | A23 | 72 | hr | 1401 | 3586 | 4223 | 0.8491 | 0.7742 |
SK-BR-3 | Imatinib | 0.12 | uM | LJP6 | 1 | N17 | 72 | hr | 1401 | 4416 | 4223 | 1.0457 | 1.0684 |
SK-BR-3 | Imatinib | 0.12 | uM | LJP6 | 2 | N17 | 72 | hr | 1401 | 4515 | 4223 | 1.0691 | 1.1035 |
SK-BR-3 | Imatinib | 0.12 | uM | LJP6 | 3 | N17 | 72 | hr | 1401 | 4746 | 4223 | 1.1238 | 1.1853 |
SK-BR-3 | JNK-9L | 0.12 | uM | LJP6 | 1 | K23 | 72 | hr | 1401 | 3570 | 4223 | 0.8454 | 0.7685 |
SK-BR-3 | JNK-9L | 0.12 | uM | LJP6 | 2 | K23 | 72 | hr | 1401 | 3306 | 4223 | 0.7828 | 0.6750 |
SK-BR-3 | JNK-9L | 0.12 | uM | LJP6 | 3 | K23 | 72 | hr | 1401 | 3445 | 4223 | 0.8158 | 0.7242 |